Qingdao-based Raise Care has reportedly secured upwards of RMB 100 million (USD 13.7 million) in a Series B financing round, according to recent reports. The round was led by CITIC Capital’s healthcare fund, with participation from CICC Capital, Jufeng S&T Venture Investment, and other investors.
Company Background and Focus
Founded in 2016, Raise Care is a company dedicated to life science research and the development, manufacturing, sales, and services of in vitro diagnostic (IVD) products. The company has established a strong presence, particularly in the field of flow cytometry, a technique widely used in biotechnology and medicine for cell counting, sorting, and analysis.
Significance of the Financing Round
The significant investment from CITIC Capital and other participants underscores the potential and growth prospects of Raise Care in the IVD market. This funding will likely accelerate the company’s research and development efforts, enhance its manufacturing capabilities, and expand its reach in the global IVD sector.-Fineline Info & Tech
